Published in BMC Med Educ on December 05, 2012
Key ingredients of anti-stigma programs for health care providers: a data synthesis of evaluative studies. Can J Psychiatry (2014) 1.63
Opening minds in Canada: targeting change. Can J Psychiatry (2014) 1.22
Opening Minds Stigma Scale for Health Care Providers (OMS-HC): examination of psychometric properties and responsiveness. BMC Psychiatry (2014) 1.19
Stigma in Canada: results from a rapid response survey. Can J Psychiatry (2014) 1.08
Mental health practice and attitudes of family physicians can be changed! Perm J (2013) 0.99
New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health (2014) 0.98
Community pharmacists' experiences in mental illness and addictions care: a qualitative study. Subst Abuse Treat Prev Policy (2016) 0.93
Partnering to enhance mental health care capacity in communities: A qualitative study of the More Than Meds program. Can Pharm J (Ott) (2015) 0.85
Pharmacy students' experiences in provision of community pharmacy mental health services. Can Pharm J (Ott) (2014) 0.84
Theoretical and Practical Considerations for Combating Mental Illness Stigma in Health Care. Community Ment Health J (2015) 0.78
Stigma towards borderline personality disorder: effectiveness and generalizability of an anti-stigma program for healthcare providers using a pre-post randomized design. Borderline Personal Disord Emot Dysregul (2015) 0.77
Workforce interventions to improve access to emergency contraception pills: a systematic review of current evidence in low- and middle-income countries and recommendations for improving performance. BMC Health Serv Res (2015) 0.77
Stigma of mental illness: A study in the Indian Armed Forces. Med J Armed Forces India (2014) 0.77
Impact of a Mental Illness Stigma Awareness Intervention on Pharmacy Student Attitudes and Knowledge. Am J Pharm Educ (2016) 0.77
Could a short training intervention modify opinions about mental illness? A case study on French health professionals. BMC Psychiatry (2017) 0.75
Risk factors of the stigma towards psychiatric patients among primary healthcare workers in China: a county study. BMC Psychiatry (2017) 0.75
Mental health curricula at schools of pharmacy in the United Kingdom and recent graduates' readiness to practice. Am J Pharm Educ (2013) 0.75
Evaluating the Impact of an Anti-stigma Intervention on Pharmacy Students' Willingness to Counsel People Living with Mental Illness. Community Ment Health J (2016) 0.75
Mental illness-related stigma in healthcare: Barriers to access and care and evidence-based solutions. Healthc Manage Forum (2017) 0.75
A meta-analytic test of intergroup contact theory. J Pers Soc Psychol (2006) 7.05
Community pharmacists' attitudes toward and professional interactions with users of psychiatric medication. Psychiatr Serv (2004) 1.57
Active ingredients in anti-stigma programmes in mental health. Int Rev Psychiatry (2005) 1.51
Peer-level patient presenters decrease pharmacy students' social distance from patients with schizophrenia and clinical depression. Am J Pharm Educ (2008) 1.45
Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy (2003) 1.44
Pharmacy students' and graduates' attitudes towards people with schizophrenia and severe depression. Am J Pharm Educ (2006) 1.30
The development and psychometric properties of a new scale to measure mental illness related stigma by health care providers: the Opening Minds Scale for Health Care Providers (OMS-HC). BMC Psychiatry (2012) 1.29
Pharmacists' role in depression care: a survey of attitudes, current practices, and barriers. Psychiatr Serv (2008) 1.29
Development and responsiveness of a scale to measure clinicians' attitudes to people with mental illness (medical student version). Acta Psychiatr Scand (2010) 1.14
A comparative study of consumer participation in mental health pharmacy education. Ann Pharmacother (2006) 1.09
Determinants of mental health stigma among pharmacy students in Australia, Belgium, Estonia, Finland, India and Latvia. Int J Soc Psychiatry (2009) 1.07
Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception (2005) 1.06
Will filmed presentations of education and contact diminish mental illness stigma? Community Ment Health J (2006) 1.02
Pharmaceutical care for people with depression: Belgian pharmacists' attitudes and perceived barriers. Int J Clin Pharm (2012) 1.01
Community pharmacist services for people with mental illnesses: preferences, satisfaction, and stigma. Psychiatr Serv (2009) 0.94
Relationship between attitudes toward mental illness and provision of pharmacy services. J Am Pharm Assoc (2003) (2010) 0.93
Consumer-led mental health education for pharmacy students. Am J Pharm Educ (2010) 0.93
Mental health consumers and caregivers as instructors for health professional students: a qualitative study. Soc Psychiatry Psychiatr Epidemiol (2011) 0.87
Influence of attitudes toward curriculum on dishonest academic behavior. Am J Pharm Educ (2006) 2.91
Public attitudes towards people with mental illness in England and Scotland, 1994-2003. Br J Psychiatry (2009) 2.24
Stigma: ignorance, prejudice or discrimination? Br J Psychiatry (2007) 1.89
Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. Gen Hosp Psychiatry (2008) 1.59
Filmed v. live social contact interventions to reduce stigma: randomised controlled trial. Br J Psychiatry (2011) 1.56
Reducing stigma and discrimination: Candidate interventions. Int J Ment Health Syst (2008) 1.56
Discrimination in health care against people with mental illness. Int Rev Psychiatry (2007) 1.52
Alternatives to atypical antipsychotics for the management of dementia-related agitation. Drugs Aging (2008) 1.44
The development and psychometric properties of a new scale to measure mental illness related stigma by health care providers: the Opening Minds Scale for Health Care Providers (OMS-HC). BMC Psychiatry (2012) 1.29
Opening Minds Stigma Scale for Health Care Providers (OMS-HC): examination of psychometric properties and responsiveness. BMC Psychiatry (2014) 1.19
Reducing the stigma of mental illness in undergraduate medical education: a randomized controlled trial. BMC Med Educ (2013) 1.15
Long-term medical conditions and major depression: strength of association for specific conditions in the general population. Can J Psychiatry (2005) 1.10
The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders. Ann Med (2012) 1.09
Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project. Can Pharm J (Ott) (2013) 1.04
Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review. Ann Pharmacother (2011) 1.02
Psychotropic medication use in Canada. Can J Psychiatry (2005) 1.00
Data safety monitoring boards and other study methodologies that address subject safety in "high-risk" therapeutic trials in youths. J Am Acad Child Adolesc Psychiatry (2007) 0.98
250 labels used to stigmatise people with mental illness. BMC Health Serv Res (2007) 0.95
Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study. Can J Psychiatry (2008) 0.95
Community pharmacist services for people with mental illnesses: preferences, satisfaction, and stigma. Psychiatr Serv (2009) 0.94
Psychotherapy and medication options for depression. Am Fam Physician (2004) 0.92
Platform switching as a means to achieving implant esthetics. N Y State Dent J (2005) 0.90
Predictors of Well-Being in Resident Physicians: A Descriptive and Psychometric Study. J Grad Med Educ (2015) 0.89
Use of selective serotonin reuptake inhibitors and youth suicide: making sense from a confusing story. Curr Opin Psychiatry (2008) 0.87
Lamotrigine-induced neutropenia. Can J Psychiatry (2005) 0.86
Mental Illness: Clinicians' Attitudes (MICA) scale-psychometric properties of a version for healthcare students and professionals. Psychiatry Res (2012) 0.85
Prescribing trends of antipsychotics in youth receiving income assistance: results from a retrospective population database study. BMC Psychiatry (2013) 0.85
Clinical trial participation among patients enrolled in the Glioma Outcomes Project. Cancer (2002) 0.84
Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele. J Alzheimers Dis (2013) 0.83
Validity and reliability of an in-training evaluation report to measure the CanMEDS roles in emergency medicine residents. CJEM (2014) 0.82
Costs of new atypical antipsychotic agents for schizophrenia: does unrestricted access reduce hospital utilization? Healthc Policy (2007) 0.82
Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders. Neuropsychiatr Dis Treat (2005) 0.80
Cardiofaciocutaneous syndrome (CFC) with congenital peripheral neuropathy and nonorganic malnutrition: an autopsy study. Am J Med Genet A (2005) 0.79
Incidence of extrapyramidal syndromes and tardive dyskinesia. J Clin Psychopharmacol (2011) 0.79
Conformity of behaviors among medical students: impact on performance of knee arthrocentesis in simulation. Adv Health Sci Educ Theory Pract (2012) 0.78
Pharmacoepidemiology of benzodiazepine and sedative-hypnotic use in a Canadian general population cohort during 12 years of follow-up. Can J Psychiatry (2010) 0.77
Liraglutide in Weight Management. N Engl J Med (2015) 0.75
The immense value of qualitative research to pharmacy. Can Pharm J (Ott) (2016) 0.75
Health Care Access and Use by Urban American Indians and Alaska Natives: Findings from the National Health Interview Survey (2006-09). J Health Care Poor Underserved (2016) 0.75